Stereotactic Body Radiation Therapy (Stereotactic Ablative Radiotherapy) for Stage I Non-Small Cell Lung Cancer - Updates of Radiobiology, Techniques, and Clinical Outcomes

被引：0
|
作者：
Hadziahmetovic, Mersiha [1 ]
Loo, Billy W. [2 ]
Timmerman, Robert D. [3 ]
Mayr, Nina A. [1 ]
Wang, Jian Z. [1 ]
Huang, Zhibin [1 ]
Grecula, John C. [1 ]
Lo, Simon S. [1 ]
机构：
[1] Ohio State Univ, Arthur G James Canc Hosp, Dept Radiat Oncol, Columbus, OH 43210 USA
[2] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA
来源：
DISCOVERY MEDICINE | 2010年 / 9卷 / 48期
关键词：
PHASE-II; TOXICITY;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Stereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), has emerged as one of the standard treatment options for stage I non-small cell lung cancer (NSCLC), mainly in medically inoperable patients. Its use has also been explored in operable patients. A large body of experience, either from retrospective studies or clinical trials, has been accumulated over the years and more is known about the radiobiology, cancer biology, technical aspects, clinical outcomes, and toxicities of SBRT. This article provides updates of these aspects of SBRT for stage I NSCLC.
引用
收藏
页码：411 / 416
页数：6
相关论文
共 50 条
  • [31] Stereotactic radiotherapy for operable stage I non-small cell lung cancer
    Martin, E.
    Nicolet, C.
    Boisselier, P.
    Khalifa, J.
    Thureau, S.
    [J]. CANCER RADIOTHERAPIE, 2023, 27 (6-7): : 648 - 652
  • [32] Stereotactic ablative radiotherapy for operable stage I non-small cell lung cancer: not ready for prime time
    Connolly, James G.
    Jones, Gregory D.
    Caso, Raul
    Jones, David R.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [33] STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN POTENTIALLY OPERABLE STAGE I NON-SMALL CELL LUNG CANCER PATIENTS
    Lagerwaard, Frank J.
    Verstegen, Naomi E.
    Haasbeek, Cornelis J.
    Slotman, Ben
    Paul, M. A.
    Smit, Egbert F.
    Senan, Suresh
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S278 - S279
  • [34] Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer
    de Ruiter, Julianne Cynthia
    van Diessen, Judi Nani Annet
    Smit, Egbert Frederik
    van der Noort, Vincent
    Damhuis, Ronald Alphons Maria
    Hartemink, Koen Johan
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 62 (03)
  • [35] Stereotactic Ablative Radiotherapy (SABR) in Potentially Operable Patients with Stage I Non-small Cell Lung Cancer
    Lagerwaard, F. J.
    Verstegen, N. E.
    Haasbeek, C. J. A.
    Slotman, B. J.
    Smit, E. F.
    Paul, M. A.
    Senan, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S79 - S80
  • [36] Stereotactic ablative radiotherapy versus lobectomy for stage I non-small cell lung cancer: A systematic review
    Wang, Siwei
    Wang, Xiaoxiao
    Zhou, Qing
    Xu, Youtao
    Xia, Wenjia
    Xu, Weizhang
    Ma, ZhiFei
    Qiu, Mantang
    You, Ran
    Xu, Lin
    Yin, Rong
    [J]. THORACIC CANCER, 2018, 9 (03) : 337 - 347
  • [37] Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer
    Crabtree, Traves D.
    Denlinger, Chadrick E.
    Meyers, Bryan F.
    El Naqa, Issam
    Zoole, Jennifer
    Krupnick, A. Sasha
    Kreisel, Daniel
    Patterson, G. Alexander
    Bradley, Jeffrey D.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 140 (02): : 377 - 386
  • [38] Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer
    Lee, Percy
    Loo Jr, Billy W.
    Biswas, Tithi
    Ding, George X.
    El Naqa, Issam M.
    Jackson, Andrew
    Kong, Feng-Ming
    LaCouture, Tamara
    Miften, Moyed
    Solberg, Timothy
    Tome, Wolfgang A.
    Tai, An
    Yorke, Ellen
    Li, X. Allen
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (01): : 160 - 171
  • [39] Stereotactic body radiation therapy for stage I non-small cell lung cancer: a small academic hospital experience
    Factor, Oren B.
    Vu, Charles C.
    Schneider, Jeffrey G.
    Witten, Matthew R.
    Schubach, Scott L.
    Gittleman, Alicia E.
    Catell, Donna T.
    Haas, Jonathan A.
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [40] Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
    Chang, Joe Y.
    Liu, Hui
    Balter, Peter
    Komaki, Ritsuko
    Liao, Zhongxing
    Welsh, James
    Mehran, Reza J.
    Roth, Jack A.
    Swisher, Stephen G.
    [J]. RADIATION ONCOLOGY, 2012, 7
12345